Gelatinase B: A tuner and amplifier of immune functions

Trends in Immunology

Volumn 22, Issue 10, 2001, Pages 571-579

  Opdenakker, Ghislain ^a   Van Den Steen, Philippe E ^a   Van Damme, Jo ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B;

AUTOIMMUNITY; BASEMENT MEMBRANE; CELL MIGRATION; CIRCULATION; ENZYME ACTIVITY; ENZYME STRUCTURE; EXTRACELLULAR MATRIX; HUMAN; IMMUNOREGULATION; LEUKOCYTE; LYMPH FLOW; LYMPHOCYTE; NONHUMAN; PROTEIN DEGRADATION; REVIEW; TUMOR CELL;

ANIMALS; DENDRITIC CELLS; HUMANS; LYMPHOCYTES; MACROPHAGES; MATRIX METALLOPROTEINASE 9; PROTEIN STRUCTURE, TERTIARY;

EID: 0035471778     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(01)02023-3     Document Type: Review

References (87)

1. Matrix metalloproteinases
2. Collagenolytic activity in amphibian tissues: A tissue culture assay
3. Human collagenase: Identification and characterisation of an enzyme from rheumatoid synovium in culture
4. Metalloproteases of human articular cartilage that digest cartilage proteoglycan at neutral and acid pH
5. Metalloproteinases and collagenase inhibitors in rheumatoid synovial fluid
6. Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis
7. Tissue inhibitors of metalloproteinases: Evolution, structure and function
8. 2-macroglobulin and tissue inhibitor of metalloproteinases: Collagenase inhibitors in human preovulatory ovaries
9. Development of matrix metalloproteinase inhibitors in cancer therapy
10. Monoclonal antibodies specific for natural human neutrophil gelatinase B used for affinity purification, quantitation by two-site ELISA and inhibition of enzymatic activity
11. SV-40-transformed human lung fibroblasts secrete a 92 kDa type IV collagenase, which is identical to that secreted by normal human macrophages
12. Complete structure of the human gene for 92 kDa type IV collagenase. Divergent regulation of expression for the 92 and 72 kDa enzyme genes in HT-1080 cells
13. Mouse gelatinase B: cDNA cloning, regulation of expression and glycosylation in WEHI-3 macrophages and gene organisation
14. Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system
15. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes
16. Resistance of young gelatinase-B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions
17. Experimental metastasis is suppressed in MMP-9-deficient mice
18. Gelatinase B functions as regulator and effector in leukocyte biology
19. The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family
20. Mechanism of cell-surface activation of 72 kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease
21. Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system
22. O-glycan analysis of natural human neutrophil gelatinase B using a combination of normal phase-HPLC and online tandem mass spectrometry: Implications for the domain organization of the enzyme
23. Structure of human pro-matrix metalloproteinase 2: Activation mechanism revealed
24. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9
25. Activation of pro-gelatinase B (MMP-9) by gelatinase A
26. Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils
27. Interaction of 92 kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase and activation of the proenzyme with stromelysin
28. Binding of tissue inhibitor of metalloproteinase 2 to two distinct sites on human 72 kDa gelatinase
29. ECM and cell surface proteolysis: Regulating cellular ecology
30. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase
31. Presence of a gelatin-specific proteinase and its latent form in human leucocytes
32. Purification of a type V collagen-degrading metalloproteinase from rabbit alveolar macrophages
33. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase
34. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4 and GRO-α, and leaves RANTES and MCP-2 intact
35. Cytokine-mediated regulation of human leukocyte gelatinases and role in arthritis
36. Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation and expression during cellular development
37. Natural human monocyte gelatinase and its inhibitor
38. Direct contact between T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expression
39. Activation of human monocytes through CD40 induces matrix metalloproteinases
40. Fibronectin-mediated cell adhesion is required for induction of 92 kDa type IV collagenase/gelatinase (MMP-9) gene expression during macrophage differentiation. The signaling role of protein kinase Cβ
41. Interleukin-4 inhibition of prostaglandin E2 synthesis blocks interstitial collagenase and 92 kDa type IV collagenase/gelatinase production by human monocytes
42. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes
43. Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon β-1b through an effect on matrix metalloproteinase 9
44. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases
45. Fibronectin-bound TNF-α stimulates monocyte matrix metalloproteinase 9 expression and regulates chemotaxis
46. Regulation of human monocyte matrix metalloproteinases by SPARC
47. Induction of metalloproteinase activity in human T lymphocytes
48. Production and regulation of gelatinase B by human T cells
49. Human T lymphocytes synthesize the 92 kDa type IV collagenase (gelatinase B)
50. Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes
51. Stimulation of matrix metalloproteinase-dependent migration of T cells by eicosanoids
52. Peptidoglycan from sterile human spleen induces T-cell proliferation and inflammatory mediators in rheumatoid arthritis patients and healthy subjects
53. Bi-directional induction of matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinase 1 during T-lymphoma-endothelial-cell contact: Implication of ICAM-1
54. Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T-lymphocyte cell lines. A process repressed through RAS-MAP kinase signaling pathways
55. An altered peptide ligand inhibits the activities of matrix metalloproteinase 9 and phospholipase C, and inhibits T-cell interactions with VCAM-1 induced in vivo by a myasthenogenic T-cell epitope
56. Interferon β-1b decreases the migration of T lymphocytes in vitro: Effects on matrix metalloproteinase 9
57. Interferon β-1b inhibits gelatinase secretion and in vitro migration of human T cells: A possible mechanism for treatment efficacy in multiple sclerosis
58. The induction of 72 kDa gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent
59. Human B lymphocytes synthesize the 92 kDa gelatinase, matrix metalloproteinase 9
60. Matrix metalloproteinases produced by rat IL-2-activated NK cells
61. Gelatinase B in chronic synovitis: Immunolocalization with a monoclonal antibody
62. Possible involvement of matrix metalloproteinase 9 in Langerhans cell migration and maturation
63. Inhibition of contact sensitizer-induced migration of human Langerhans cells by matrix metalloproteinase inhibitors
64. Human monocyte-derived dendritic cells produce bioactive gelatinase B: Inhibition by interferon β
65. Selective regulation of metalloproteinase inhibitor (TIMP-1) by oncostatin M in fibroblasts in culture
66. Human osteoblasts in culture synthesize collagenase and other matrix metalloproteinases in response to osteotropic hormones and cytokines
67. Airway epithelial-cell migration dynamics. MMP-9 role in cell-extracellular matrix remodeling
68. The molecular basis of leukocytosis
69. Prevention of interleukin-8-induced mobilization of haematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against gelatinase B (MMP-9)
70. In vivo neutrophil recruitment by granulocyte chemotactic protein 2 is assisted by gelatinase B/MMP-9 in the mouse
71. Gelatinase B deficiency impairs reproduction
72. Gelatinase-B-deficient mice are resistant to experimental bullous pemphigoid
73. Matrix metalloproteinase deficiencies affect contact hypersensitivity: Stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response
74. Cytokine-regulated proteases in autoimmune diseases
75. Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein
76. Generation of biologically active IL-1β by matrix metalloproteinases: A novel caspase-1-independent pathway of IL-1β processing
77. CD26, let it cut or cut it down
78. Three-dimensional structure of interleukin-8 in solution
79. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein 3
80. A novel role of metalloproteinase in cancer-mediated immunosuppression
81. CD44v(3,8-10) is involved in cytoskeleton-mediated tumor-cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells
82. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion
83. The structural basis for the elastolytic activity of the 92 kDa and 72 kDa gelatinases. Role of the fibronectin-type-II-like repeats
84. Involvement of fibronectin type II repeats in the efficient inhibition of gelatinases A and B by long-chain unsaturated fatty acids
85. Pharmacological inhibition of gelatinase B induction and tumor-cell invasion
86. Prevention of cytokine-induced changes in leukocyte adhesion receptors by nonsteroidal anti-inflammatory drugs from the oxicam family
87. HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages